108655-21-6

Basic information

• Product Name: 3-(m-Aminophenyl)pyridazine
• Synonyms: 3-(m-Aminophenyl)pyridazine
• CAS NO: 108655-21-6
• Molecular Weight: 171.202
• Mol File: 108655-21-6.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 3-(m-Aminophenyl)pyridazine(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(m-Aminophenyl)pyridazine(108655-21-6)
• EPA Substance Registry System: 3-(m-Aminophenyl)pyridazine(108655-21-6)

Safety Data

• Hazardous Substances Data: 108655-21-6(Hazardous Substances Data)

Upstream product

• 1120-95-2 3-chloropyridazine 
• 30418-59-8 3-Aminophenylboronic acid 
• 54558-01-9 3-(m-Nitrophenyl)-6-oxo-1,6-dihydropyridazine 
• 6328-00-3 4-(3-nitro-phenyl)-4-oxo-butyric acid 
• 52239-76-6 3-(m-Nitrophenyl)-6-oxo-1,4,5,6-tetrahydropyridazine 
• 58059-33-9 3-chloro-6-(3-nitrophenyl)pyridazine 

Downstream Products

• 333792-55-5 N-(3-(pyridazin-3-yl)phenyl)-9H-fluorene-1-carboxamide 

Relevant articles and documents

ARYL AND HETEROARYL COMPOUNDS, AND THERAPEUTIC USES THEREOF IN CONDITIONS ASSOCIATED WITH THE ALTERATION OF THE ACTIVITY OF GALACTOCEREBROSIDASE

The application is directed to compounds of formulae (IA) and (IB): (IA) and (IB), and their salts and solvates, wherein R1a, R2a, A1, A2, A3, A4, R1b, R2b, B1, B2, B3, and G are as set forth in the specification, as well as to methods for their preparation, pharmaceutical compositions comprising the same, and use thereof for the treatment and/or prevention of, e.g., lysosomal storage diseases, such as Krabbe's disease, and α-synucleinopathies, such as Parkinson's disease.

QUANTITATIVE DETERMINATION OF THE ELECTRONIC EFFECTS OF 3- AND 4-PYRIDAZINYL GROUPS FROM NMR SPECTRAL DATA FOR ISOMERIC AMINOPHENYL- AND PHENYLPYRIDAZINES

The previously unknown aminophenylpyridazines were synthesized.The inductive and resonance constants of 3- and 4-pyridazinyl groups were calculated on the basis of 1H and 13C NMR spectral data for isomeric aminophenyl- and phenylpyridazines in dimethyl sulfoxide (DMSO).